European Wellness Biomedical Group Announces New Klotho Research Initiative Led by Prof. Mike Chan
HEIDELBERG, Germany, Dec. 25, 2024 /PRNewswire/ -- European Wellness Biomedical Group (EWBG) has launched a new research initiative focused on Klotho, a protein with transformative potential in longevity medicine. Led by Professor Dr. Mike Chan, this project will explore Klotho's role in combating age-related diseases and its ability to regenerate critical organs, including...
Designs For Health Inc. Held Liable For Infringement of Kaneka’s Ubiquinol Patent
TOKYO, Dec. 25, 2024 /PRNewswire/ -- Kaneka has successfully defended its patent for stabilizing Ubiquinol. On December 20, 2024, Kaneka Corporation won its lawsuit against Designs for Health, Inc. and American River Nutrition, LLC for infringement of Kaneka's U.S. Patent No. 7,829,080 (the "'080 Patent"). The '080 Patent teaches a method of stabilizing...
Health In Tech Announces Closing of Initial Public Offering
STUART, Fla., Dec. 25, 2024 /PRNewswire/ -- Health In Tech, an Insurtech platform company backed by third-party AI technology, today announced the closing of its initial public offering of 2,300,000 shares of its Class A common stock at a public offering price of $4.00 per share, for gross proceeds of $9,200,000, before...
Step Into 2025 with Fresh Air: QNET’s HomePure Zayn Sets the Standard for Clean, Healthy Living
HONG KONG, Dec. 24, 2024 /PRNewswire/ -- With air pollution posing a growing global health threat, QNET's HomePure Zayn remains a household staple, delivering pure, revitalised indoor air. As we enter 2025, HomePure Zayn is more essential than ever, trusted by families worldwide to protect their homes from pollutants and ensure a healthier, cleaner living environment. QNET’s HomePure Zayn...
Ractigen Therapeutics Announces First Patient Dosed in Phase I Clinical Trial for RAG-17 in SOD1-ALS
NANTONG and SUZHOU, China, Dec. 24, 2024 /PRNewswire/ -- Ractigen Therapeutics, a clinical-stage pharmaceutical company dedicated to developing RNA-based innovative therapies, today announced the successful dosing of the first patient in the Phase I clinical trial of RAG-17, an innovative siRNA therapy targeting Amyotrophic Lateral Sclerosis (ALS) associated with superoxide dismutase 1 (SOD1) gene mutations at Second Affiliated Hospital of...
One More Certificate: Syrebo Hand Rehabilitation Robot Achieves TGA Certification in Australia
SHANGHAI, Dec. 24, 2024 /PRNewswire/ -- Syrebo, a global leader in rehabilitation robotics, is proud to announce that its Hand Rehabilitation Robot has been granted official certification by the Therapeutic Goods Administration (TGA), marking a significant achievement in the company's mission to advance medical rehabilitation technology. The Syrebo Hand Rehabilitation Robot is a cutting-edge, robotic-assisted device...
NEC Thailand Partners with Umong Municipality, Lamphun Province to Develop Digital Technology Platform for Elderly Care and Smart City Advancement
LAMPHUN, Thailand, Dec. 24, 2024 /PRNewswire/ -- NEC Corporation (Thailand) Ltd., or NEC Thailand, has signed a Memorandum of Understanding (MoU) with Umong Municipality in Lamphun Province to jointly develop a digital technology platform aimed at enhancing elderly care and supporting dependent patients, including homebound and bedridden individuals. This collaboration is part of...
Inauguration of MRI Facility and Health Service Initiative at Bhayangkara Kediri Hospital, Featuring DNA Testing Services in Collaboration with Regene Genomics
JAKARTA and KEDIRI, Indonesia, Dec. 24, 2024 /PRNewswire/ -- Bhayangkara Kediri Hospital inaugurated its new MRI service building and laid the cornerstone for a new service facility, marking a significant step forward in enhancing healthcare services in Kediri and surrounding areas. The festive inauguration ceremony was led by Head of the Central Police Hospital, Police...
Medit Launches a Mobile App, MEDIT M, to Revolutionize Digital Dental Workflows
SEOUL, South Korea, Dec. 23, 2024 /PRNewswire/ -- Medit has launched a mobile app, MEDIT M, available to users starting December 18, 2024. MEDIT M This much-anticipated release addresses key features requested by dental professionals and aims to improve collaboration and efficiency between clinics and labs. Key Features Real-Time...
Keymed Biosciences Announces Approval Of Stapokibart For The Treatment Of Chronic Rhinosinusitis With Nasal Polyposis
CHENGDU, China, Dec. 23, 2024 /PRNewswire/ -- Keymed Biosciences Inc. (HKEX: 02162) today announced the National Medical Products Administration (the "NMPA") of China has recently approved the supplemental New Drug Application (the "sNDA") of Stapokibart (anti-IL-4Rα monoclonal antibody, trade name: 康悦达, R&D codename: CM310), for the treatment of chronic rhinosinusitis with nasal polyposis. The approval is based on a...
